Back to search

Article

The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells <i>in vitro</i> : implications for the STEM-PD clinical trial

2024-01-24

Abstract excerpt

<h4>Summary</h4> Parkinson’s Disease involves the progressive loss of dopaminergic neurons (DAn), prompting clinical trials replacing cell loss with neural grafts. This includes the transplantation of pluripotent stem cell-derived DAn progenitor cells (NPC) currently under investigation in the STEM-PD trial. To determine the likelihood of immune rejection post-grafting, we characterised the immunogenicity of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e62a167-463c-5806-a3cc-4e71ef2743f6
DOI
10.1101/2024.01.23.576826
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells <i>in vitro</i> : implications for the STEM-PD clinical trialDOI 10.1101/2024.01.23.576826
Select a neighboring publication to make it the new centre.